Commerce Bank’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,199
| Closed | -$484K | – | 1215 |
|
|
2024
Q3 | $484K | Buy |
4,199
+108
| +3% | +$12.4K | ﹤0.01% | 896 |
|
|
2024
Q2 | $563K | Buy |
+4,091
| New | +$563K | ﹤0.01% | 808 |
|
|
2022
Q2 | – | Sell |
-2,166
| Closed | -$203K | – | 1180 |
|
|
2022
Q1 | $203K | Buy |
+2,166
| New | +$203K | ﹤0.01% | 1133 |
|
|
2021
Q3 | – | Sell |
-6,176
| Closed | -$601K | – | 1174 |
|
|
2021
Q2 | $601K | Sell |
6,176
-12
| -0.2% | -$1.17K | ﹤0.01% | 766 |
|
|
2021
Q1 | $602K | Buy |
6,188
+280
| +5% | +$27.2K | ﹤0.01% | 749 |
|
|
2020
Q4 | $567K | Buy |
5,908
+2,065
| +54% | +$198K | ﹤0.01% | 726 |
|
|
2020
Q3 | $370K | Buy |
3,843
+63
| +2% | +$6.07K | ﹤0.01% | 788 |
|
|
2020
Q2 | $461K | Sell |
3,780
-12
| -0.3% | -$1.46K | ﹤0.01% | 694 |
|
|
2020
Q1 | $328K | Buy |
3,792
+1,177
| +45% | +$102K | ﹤0.01% | 730 |
|
|
2019
Q4 | $281K | Buy |
+2,615
| New | +$281K | ﹤0.01% | 847 |
|